Rocket Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2013 | — | $-38.9M | $12.8M |
| FY2014 | — | $-51.6M | $3.6M |
| FY2015 | — | $15.5M | $80.0M |
| FY2016 | — | $8.4M | $29.8M |
| FY2017 | — | $15.5M | $18.1M |
| FY2018 | — | $194.0M | $111.4M |
| FY2019 | — | $307.3M | $185.4M |
| FY2020 | — | $503.5M | $297.1M |
| FY2021 | — | $454.7M | $232.7M |
| FY2022 | — | $489.7M | $140.5M |